Financials
- Market Capitalization 37.96 B
- Employee 33 K
- Founded N/A
- CEO Richard Francis
- Website www.tevapharm.com
- Headquarter Israel
- FIGI BBG000C0CD58
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
25.79
ratio cours/chiffre d'affaires
2.1
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 352 | HLN Haleon plc American Depositary Shares | 9.85 USD | +0.92% | +1.34% | +8.00% | -0.81% | 44.09 B USD | ||
| 434 | ZTS Zoetis Inc. Class A Common Stock | 75.45 USD | -0.11% | +0.17% | -8.38% | -48.43% | 31.63 B USD | ||
| 505 | TAK Takeda Pharmaceutical Company Limited American Depositary Share | 16.46 USD | -0.60% | -2.83% | +2.88% | +16.04% | 25.64 B USD | ||
| 613 | VTRS Viatris Inc. - Common Stock | 16.39 USD | +0.74% | -2.96% | -0.49% | +58.36% | 19.09 B USD |